I could not locate a specific $150.0 million Note Purchase Agreement dated January 13, 2025, in the available SEC filings. My search did identify several companies that entered into various note purchase agreements or related financing activities around January 2025, but none precisely match the specified amount and date.
Here are some of the notable financing activities from January 2025:
- 5E Advanced Materials Inc., on January 14, 2025, amended its "January 2024 Amended and Restated Note Purchase Agreement" to issue and sell $5.0 million in new senior secured convertible notes. This agreement was subsequently terminated on March 5, 2025, as part of a restructuring.1
- W&T Offshore, Inc. commenced a Tender Offer on January 13, 2025, for its outstanding 11.75% Notes, ultimately purchasing $269.7 million aggregate principal amount of these notes. This was a tender offer to repurchase existing notes, not a new $150.0 million note purchase agreement.2
- Suro Capital Corp. issued and sold $5.0 million in aggregate principal amount of "Additional Notes" on January 16, 2025, under an existing Note Purchase Agreement.3
- CaliberCos, Inc. entered into Preferred Subscription Agreements on January 31, 2025, which included the purchase of $2 million of Series A Convertible Preferred Stock by an accredited investor.1
- Cyclo Therapeutics, Inc. had a "Seventh Amended and Restated Note Purchase Agreement" dated January 3, 2025, and an "Eighth Amended and Restated Note Purchase Agreement" dated February 4, 2025, involving convertible promissory notes in smaller amounts.3
- La Rosa Holdings Corp. repaid a promissory note in January 2025 and entered into a securities purchase agreement in February 2025 for a Senior Secured Convertible Note in the original principal amount of $5.5 million.4
While these companies engaged in note-related transactions in January 2025, none directly correspond to a $150.0 million Note Purchase Agreement on January 13, 2025. If you have more specific details, such as the company involved, I may be able to provide a more targeted analysis.
